Watson Pharma (WPI) Posts Q3 adj.-EPS of $0.66, Beats by 1c;
More News related to WPI
- StockPreacher.com Issues Trading Outlook for Arena Pharmaceuticals Inc.
- Watson Names Robert A. Stewart Senior Vice President, Global Operations
- Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference
- Watson to Present at Credit Suisse Healthcare Conference
- Watson Pharma (WPI) Posts Q3 adj.-EPS of $0.66, Beats by 1c;
More News related to Earnings
- Hydrogenics Resumes Trading Under NASDAQ Symbol "HYGS"
- Varian Medical (VAR) to Highlight its New Range of Detectors at Annual RSNA Meeting in Chicago
- Manulife (MFC) Confirms No Exposure to Dubai World
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Seiko Epson to Transfer Sales Function of Small and Medium-Sized TFT LCD Business to Sony (SNE)
Watson Pharmaceuticals, Inc. (NYSE: WPI) reports Q3 adjusted EPS of $0.66, 1 cent better than the analyst estimate of $0.65. Revenue for the quarter was $662.10 million, which compares to the estimate of $688.53 million.
Related Categories
EarningsStocks Mentioned
-0.85Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
